Quadrant Eye is Other Healthcare Services in United States that focus on related macular degeneration business. Founded in 2020. They cover business area such as developer, an eye care platform, instant and reliable remote eye exam, screening, diagnosis, management, low-acuity and chronic eye problem, cataract, glaucoma, age-relate macular degeneration, diabetic retinopathy, home, patient, treatment, diabetic eye disease.
2020
( 4 years old in 2024 )
Related Macular Degeneration
-
548 Market Street
PMB 94422
San Francisco, CA 94104
United States
Private
developeran eye care platforminstant and reliable remote eye examscreeningdiagnosismanagementlow-acuity and chronic eye problemcataractglaucomaage-relate macular degenerationdiabetic retinopathyhomepatienttreatmentdiabetic eye disease
* We use standard office opening hours in near Quadrant Eye's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Quadrant Eye is Other Healthcare Services business from United States that founded in 2020 (4 years old in 2024), Quadrant Eye business is focusing on Related Macular Degeneration.
Quadrant Eye headquarter office and corporate office address is located in 548 Market Street PMB 94422 San Francisco, CA 94104 United States.
Quadrant Eye was founded in United States.
In 2024, Quadrant Eye is currently focus on related macular degeneration sector.
Above is snippet of Google Trends for "related macular degeneration" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Quadrant Eye, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
